Guerra-Amor A, Lopez-Gonzalez A, Bosch-Nicolau P, Rodriguez-Acevedo B, Zabalza A, Sulleiro E, Espinosa-Pereiro J, Aznar ML, Salvador F, Sanchez-Montalva A, Molina I
In this report, we present a case of visceral leishmaniasis in a patient with multiple sclerosis (MS) under fingolimod treatment. We discuss the previously published cases of MS patients under different immunosuppressant therapies to highlight its risk in endemic areas and suggest a therapeutic approach.